“…Various nucleic acid-mediated reactions have been exploited in PADs, including simple DNA hybridization [378,379,389,395,409] and complex reactions, such as PCR [415], RPA [398,416], RCA [396,399,417], and SDA [418,419]. The sensing interfaces are composed of oligonucleotide monolayers [379,412,420], composite multilayer [378,409] and 3D nucleic acid materials [399,410] or oligonucleotide-containing heterogeneous nanostructures [123]. The analysts include small molecules [375,421], miRNAs [378], DNA strands [123,379,412,420], proteins [375,379,391,422], exosomes [409], cancer cells [422], papillomavirus [389], pathogens [408] and so on, implying the great potential of nucleic acid-based PADs in enormous applications.…”